Dr. Mukherjee on Radioactive Iodine Treatment of Thyroid Cancer and Risk of MDS

CLICK HERE for the Hypothyroidism Revolution Program!
#thyroid #thyroidsymptoms #thyroidtreatment #thyroidtest

Sudipto Mukherjee, MD, associate staff, Department of Hematology and Oncology, Cleveland Clinic, discusses a study examining the association between radioactive iodine treatment of thyroid cancer and the risk of developing myelodysplastic syndromes (MDS).

Leave a Reply

Your email address will not be published. Required fields are marked *